Carlsson J - Search Results

1

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.

Steffen AC, Orlova A, Wikman M, Nilsson FY, Ståhl S, Adams GP, Tolmachev V, Carlsson J. Steffen AC, et al. Among authors: carlsson j. Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):631-8. doi: 10.1007/s00259-005-0012-3. Epub 2006 Mar 15. Eur J Nucl Med Mol Imaging. 2006. PMID: 16538504

2

Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition.

Sundberg AL, Almqvist Y, Tolmachev V, Carlsson J. Sundberg AL, et al. Among authors: carlsson j. Eur J Nucl Med Mol Imaging. 2003 May;30(5):727-9. doi: 10.1007/s00259-003-1129-x. Epub 2003 Mar 7. Eur J Nucl Med Mol Imaging. 2003. PMID: 12740721

3

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.

Sundberg AL, Almqvist Y, Orlova A, Blomquist E, Jensen HJ, Gedda L, Tolmachev V, Carlsson J. Sundberg AL, et al. Among authors: carlsson j. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1348-56. doi: 10.1007/s00259-003-1308-9. Epub 2003 Aug 21. Eur J Nucl Med Mol Imaging. 2003. PMID: 12937952

4

Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.

Nordberg E, Steffen AC, Persson M, Sundberg AL, Carlsson J, Glimelius B. Nordberg E, et al. Among authors: carlsson j. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):771-7. doi: 10.1007/s00259-005-1761-8. Epub 2005 Mar 12. Eur J Nucl Med Mol Imaging. 2005. PMID: 15765233

5

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.

Steffen AC, Wikman M, Tolmachev V, Adams GP, Nilsson FY, Ståhl S, Carlsson J. Steffen AC, et al. Among authors: carlsson j. Cancer Biother Radiopharm. 2005 Jun;20(3):239-48. doi: 10.1089/cbr.2005.20.239. Cancer Biother Radiopharm. 2005. PMID: 15989469

6

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.

Persson M, Tolmachev V, Andersson K, Gedda L, Sandström M, Carlsson J. Persson M, et al. Among authors: carlsson j. Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1457-62. doi: 10.1007/s00259-005-1902-0. Epub 2005 Sep 29. Eur J Nucl Med Mol Imaging. 2005. PMID: 16193312

7

Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.

Orlova A, Nilsson FY, Wikman M, Widström C, Ståhl S, Carlsson J, Tolmachev V. Orlova A, et al. Among authors: carlsson j. J Nucl Med. 2006 Mar;47(3):512-9. J Nucl Med. 2006. PMID: 16513621 Free article.

8

Effects of HER2-binding affibody molecules on intracellular signaling pathways.

Ekerljung L, Steffen AC, Carlsson J, Lennartsson J. Ekerljung L, et al. Among authors: carlsson j. Tumour Biol. 2006;27(4):201-10. doi: 10.1159/000093023. Epub 2006 Apr 27. Tumour Biol. 2006. PMID: 16651854

9

Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.

Steffen AC, Almqvist Y, Chyan MK, Lundqvist H, Tolmachev V, Wilbur DS, Carlsson J. Steffen AC, et al. Among authors: carlsson j. Oncol Rep. 2007 May;17(5):1141-7. Oncol Rep. 2007. PMID: 17390057

10

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.

Nordberg E, Friedman M, Göstring L, Adams GP, Brismar H, Nilsson FY, Ståhl S, Glimelius B, Carlsson J. Nordberg E, et al. Among authors: carlsson j. Nucl Med Biol. 2007 Aug;34(6):609-18. doi: 10.1016/j.nucmedbio.2007.05.010. Nucl Med Biol. 2007. PMID: 17707800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

925 results

Search Page

Filters